Hematologic Malignancies
Conference Coverage
Characterization of Hematology Consults for Complete Blood Count Abnormalities: A Single Center Experience in the Era of Electronic Consultation
Abstract 2: 2017 AVAHO Meeting
News
Less lenalidomide may be more in frail elderly multiple myeloma patients
Starting patients on a reduced dose and increasing it gradually while monitoring carefully for adverse events, meant patients did not have to stop...
Conference Coverage
Four drugs better than three for myeloma induction
MADRID – Adding the proteasome inhibitor carfilzomib to induction regimens delivered quicker and deeper remissions.
Conference Coverage
Avelumab induces response in Hodgkin lymphoma after failed allo-SCT
LUGANO, SWITZERLAND – The immune checkpoint inhibitor avelumab showed efficacy against classical Hodgkin lymphoma among patients with disease...
News
A New ‘Triplet’ Treatment for Multiple Myeloma
A combination of 3 different types of inhibitors has recently been shown to be effective in the treatment of patients with multiple myeloma...
News
Atypical Femoral Fracture Due to Daily Ibandronate
Atypical femoral fracture is rare, but incidence grows with prolonged treatment.
Conference Coverage
Infections may trigger leukemia in the genetically susceptible
MADRID – Leukemia may have a previously unconsidered cause in some patients.
Conference Coverage
Chemo-free induction in MCL keeps getting better
Lugano, Switzerland –
Conference Coverage
Sequential triple therapy produces high response rates in CLL
“Sequential triple-T” (tailored and targeted treatment) aimed at complete eradication of MRD looks promising for CLL.
Article
Patients With Cancer Have Higher Plasma Brain Natriuretic Peptide Levels
Researchers analyzed patient data to determine the correlation of brain natriuretic peptide levels with cancer diagnosis.